Home > Quotes > BLRX > Company News

BioLineRx Ltd. News Headlines

BLRX 
$1.63
*  
0.05
  negative  
2.98%
Get BLRX Alerts
*Delayed - data as of May 24, 2013 11:50 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    BLRX Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
5/20/2013 10:32:00 AM - Seeking Alpha

BIOL Does A Deal, BLRX's Lined Up Events, CBST On Fast Track, KERX On Watch
5/7/2013 10:36:00 PM - RTT News

BioLineRx Pipeline Returns To The Winner's Circle
5/1/2013 8:43:00 AM - Seeking Alpha

BioLineRx To Present At Needham Healthcare Conference ; Webcast At 3:40 PM ET
4/30/2013 2:43:00 PM - RTT News

BioLineRx Enrolls First Patient In Phase I/II Trial For BL-8020
4/29/2013 7:37:00 AM - RTT News

Positive Data on BioLineRx Treatment - Analyst Blog
4/18/2013 7:12:18 PM - Zacks.com

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
4/17/2013 8:58:00 AM - Dow Jones Business News

BioLineRx Announces Positive Phase IIa Results For BL-7040 - Quick Facts
4/17/2013 7:24:00 AM - RTT News

BioLineRx to Start BL-8040 Study - Analyst Blog
4/16/2013 7:09:09 PM - Zacks.com

AEZS, BLRX Move Up, ASTX, PFE Hit New Highs, ACT Buys Peace, MEIP To Watch Out
4/10/2013 11:12:00 PM - RTT News

BioLineRx Receives US Approvals For Phase IIa Trial Of AML Compound BL-8040
4/10/2013 7:27:00 AM - RTT News

Upcoming Trial Data May Help Salvage Bioline Rx
4/3/2013 2:14:00 PM - Seeking Alpha

Pipeline Setback at BioLineRx - Analyst Blog
3/25/2013 4:29:40 PM - Zacks.com

ANAC, ACCP To Watch Out For, BLRX Slumps, ICAD Gets FDA Nod, STEM Grows Patent
3/20/2013 9:55:00 PM - RTT News

BioLineRx To Halt Schizophrenia Drug Trial, Stock Sinks - Update
3/20/2013 12:38:00 PM - RTT News

BioLineRx Reports Interim Analysis Phase II/III CLARITY Trial Results Of BL-1020
3/20/2013 9:09:00 AM - RTT News

BioLineRx to Initiate HCV Study - Analyst Blog
3/15/2013 4:45:23 PM - Zacks.com

BioLineRx Says French Authorities Approve Phase I/II Trial For BL-8020
3/13/2013 7:32:00 AM - RTT News

BioLineRx Q4 12 Earnings Conference Call At 10:00 AM ET
3/12/2013 9:01:00 AM - RTT News

3 Biopharma Catalyst Trades To Consider For Today
2/6/2013 12:23:37 PM - Trefis

BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drug
1/15/2013 8:01:00 AM - Seeking Alpha

BioLineRx: Israeli Biotech Incubator With Multiple Near-Term Clinical Catalysts
12/6/2012 10:04:00 AM - Seeking Alpha

A Capital-Efficient Prescription For New Drugs: Raghuram "Ram" Selvaraju
11/1/2012 4:52:00 PM - Seeking Alpha

A New And Interesting Addition To The Hep C Clinical Pipeline
10/17/2012 12:30:00 PM - Seeking Alpha

Closer Look: BioLineRx Snags Another Hep-C License Agreement
2/7/2012 10:37:00 AM - Seeking Alpha